View in EDS

CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.

Saved in:
Bibliographic Details
Title: CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
Transliterated Title: CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen.
Authors: Werner R; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany., Haug A; Clinical Department of Nuclear Medicine, University Hospital AKH Vienna, Wien, Austria., Buske C; Institute of Experimental Cancer Research, Ulm University Hospital, Ulm, Germany., Heidegger S; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany., Illert AL; Department of Hematology and Oncology, Freiburg University Hospital, Freiburg, Germany., Bassermann F; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany., Herhaus P; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany., Buck A; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany., Duell J; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Topp MS; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Kraus S; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Einsele H; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany., Lapa C; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Raderer M; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria., Lenz G; Department of Medicine A - Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Habringer S; Department of Hematology, Oncology and Cancer Immunology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany., von Tresckow B; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany., Keller U; Department of Hematology, Oncology and Cancer Immunology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany.
Source: Nuklearmedizin. Nuclear medicine [Nuklearmedizin] 2024 Apr; Vol. 63 (2), pp. 57-61. Date of Electronic Publication: 2024 Jan 08.
Publication Type: Journal Article
Journal Info: Publisher: Thieme Country of Publication: Germany NLM ID: 7609387 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2567-6407 (Electronic) Linking ISSN: 00295566 NLM ISO Abbreviation: Nuklearmedizin Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38190998
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
– Name: TitleTranslated
  Label: Transliterated Title
  Group: TiAlt
  Data: CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Werner+R%22">Werner R</searchLink>; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Haug+A%22">Haug A</searchLink>; Clinical Department of Nuclear Medicine, University Hospital AKH Vienna, Wien, Austria.<br /><searchLink fieldCode="AU" term="%22Buske+C%22">Buske C</searchLink>; Institute of Experimental Cancer Research, Ulm University Hospital, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Heidegger+S%22">Heidegger S</searchLink>; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany.<br /><searchLink fieldCode="AU" term="%22Illert+AL%22">Illert AL</searchLink>; Department of Hematology and Oncology, Freiburg University Hospital, Freiburg, Germany.<br /><searchLink fieldCode="AU" term="%22Bassermann+F%22">Bassermann F</searchLink>; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany.<br /><searchLink fieldCode="AU" term="%22Herhaus+P%22">Herhaus P</searchLink>; Department of Medicine III, School of Medicine, Technical University of Munich, Munchen, Germany.<br /><searchLink fieldCode="AU" term="%22Buck+A%22">Buck A</searchLink>; Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Duell+J%22">Duell J</searchLink>; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Topp+MS%22">Topp MS</searchLink>; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Kraus+S%22">Kraus S</searchLink>; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Einsele+H%22">Einsele H</searchLink>; Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.<br /><searchLink fieldCode="AU" term="%22Lapa+C%22">Lapa C</searchLink>; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.<br /><searchLink fieldCode="AU" term="%22Raderer+M%22">Raderer M</searchLink>; Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.<br /><searchLink fieldCode="AU" term="%22Lenz+G%22">Lenz G</searchLink>; Department of Medicine A - Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany.<br /><searchLink fieldCode="AU" term="%22Habringer+S%22">Habringer S</searchLink>; Department of Hematology, Oncology and Cancer Immunology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22von+Tresckow+B%22">von Tresckow B</searchLink>; Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Keller+U%22">Keller U</searchLink>; Department of Hematology, Oncology and Cancer Immunology, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charite Universitatsmedizin Berlin, Berlin, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227609387%22">Nuklearmedizin. Nuclear medicine</searchLink> [Nuklearmedizin] 2024 Apr; Vol. 63 (2), pp. 57-61. <i>Date of Electronic Publication: </i>2024 Jan 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Thieme%22">Thieme </searchLink><i>Country of Publication: </i>Germany <i>NLM ID: </i>7609387 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2567-6407 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200295566%22">00295566 </searchLink><i>NLM ISO Abbreviation: </i>Nuklearmedizin <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38190998
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1055/a-2194-9965
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 57
    Titles:
      – TitleFull: CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Werner R
      – PersonEntity:
          Name:
            NameFull: Haug A
      – PersonEntity:
          Name:
            NameFull: Buske C
      – PersonEntity:
          Name:
            NameFull: Heidegger S
      – PersonEntity:
          Name:
            NameFull: Illert AL
      – PersonEntity:
          Name:
            NameFull: Bassermann F
      – PersonEntity:
          Name:
            NameFull: Herhaus P
      – PersonEntity:
          Name:
            NameFull: Buck A
      – PersonEntity:
          Name:
            NameFull: Duell J
      – PersonEntity:
          Name:
            NameFull: Topp MS
      – PersonEntity:
          Name:
            NameFull: Kraus S
      – PersonEntity:
          Name:
            NameFull: Einsele H
      – PersonEntity:
          Name:
            NameFull: Lapa C
      – PersonEntity:
          Name:
            NameFull: Raderer M
      – PersonEntity:
          Name:
            NameFull: Lenz G
      – PersonEntity:
          Name:
            NameFull: Habringer S
      – PersonEntity:
          Name:
            NameFull: von Tresckow B
      – PersonEntity:
          Name:
            NameFull: Keller U
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 04
              Text: 2024 Apr
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2567-6407
          Numbering:
            – Type: volume
              Value: 63
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Nuklearmedizin. Nuclear medicine
              Type: main
ResultId 1